Positive expression of HIF-1α was found in 57.7% of all the tumor samples from all clinical stages, and the degree of positive staining for SHH, PTCH1 and GLI1 was 64.8%, 46.5%, and 54.9%, respectively (Table 1; S4 Table). The gene discussed is HIF1A; the disease is neoplasm.